Global Aerosol Delivery Devices Market was valued at USD 33.95 billion in 2021, by DelveInsight

The Global Aerosol Delivery Devices market was valued at USD 33.95 billion in 2021, growing at a CAGR of 5.38% during the forecast period from 2022 to 2027, in order to reach USD 46.50 billion by 2027. The aerosol delivery devices market is gaining momentum owing to the rapidly rising cases of respiratory disorders such as asthma, chronic obstructive pulmonary disorders (COPD), and others. Moreover, decreasing air quality in industrialized areas due to increasing air pollution is also a key factor driving the aerosol delivery devices market. In addition, the growing adoption of digital technology by key pharmaceutical players to provide better respiratory disorder management solutions along with the increase in product approvals will contribute to the aerosol delivery devices market growth.

Global Aerosol Delivery Devices Overview

Aerosol Delivery Devices are portable devices used to deliver medications for chronic obstructive pulmonary disease (COPD) and asthma into the airways. They are used to prevent and treat exacerbations of these chronic conditions. They offer the advantage of avoiding the systemic effects of drugs while ensuring that drugs are delivered right where they are needed.

Download Sample Report- https://www.delveinsight.com/sample-request/aerosol-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Regions covered in the report
• Global

Recent Developmental Activities in the Aerosol Delivery Devices Market:

• In September 2020, GlaxoSmithKline plc and Innoviva, Inc. received FDA approval for Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US.
• In July 2020, Novartis received the European Commission (EC) approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside treatment for uncontrolled asthma in the EU.
• In January 2020, Aptar Pharma partnered with Lupin to launch India's first connected smart device for respiratory disease, ADHERO.

Key Takeaways from the Aerosol Delivery Devices Market Report Study

• Market size analysis for current Aerosol Delivery Devices market size (2020), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this Aerosol Delivery Devices market is significant. To capture and analyze suitable indicators, our experts are closely watching the Aerosol Delivery Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Aerosol Delivery Devices Market.
• Various opportunities available for the other competitor in the Aerosol Delivery Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Aerosol Delivery Devices market growth in the coming future?

Aerosol Delivery Devices Market Dynamics

The increase in demand for aerosol delivery devices is predominantly attributed to the rising prevalence of pulmonary disorders such as cystic fibrosis, COPD, and others across the globe. For instance, asthma is a major chronic respiratory disease affecting both adults and children. According to the data released by the World Health Organization (WHO) in the year 2021, approximately 262 million people worldwide were affected by asthma in the year 2019. The report also stated that most of the asthma-related cases occurred in low- and lower-middle-income countries. Moreover, as per the Global Asthma Report 2018, in India, about 6% of children and 2% of adults have asthma in the same year. Therefore, the growing cases of asthma will lead to increase demand for various aerosol delivery devices as these inhalers allow the medication to directly enter into the lungs when breathed through the mouth thereby relaxing the muscles and opening the airway, allowing more air to move in and out of the lungs for easy and comfortable breathing.

COVID19 Impact on the Aerosol Delivery Devices Market

Also, the unprecedented outbreak of the COVID-19 pandemic is expected to have a limited effect on the Aerosol Delivery Devices market. This is because COVID infection severely affects the lungs and it is estimated that people may develop respiratory illness as an after effect which will surge the demand for Aerosol Delivery Devices among the COVID recovering patients. Also, various clinical trials are ongoing at present to study the efficacy of asthma inhalers on COVID-19 patients. Furthermore, the launch of vaccines and their administration across the globe will normalize the market situation in the post-pandemic situation.

Aerosol Delivery Devices Market Segment Analysis

• Aerosol Delivery Devices Market By Product Type (Dry Powder Inhaler, Metred Dose Inhaler, Soft Mist Inhaler, Nebulizers [Ultrasonic Nebulizers, Mesh Nebulizers, and Compressor Nebulizers]),
• Aerosol Delivery Devices Market By Type (Conventional Inhaler Devices and Smart Inhaler Devices),
• Aerosol Delivery Devices Market By Patient Type (Adult and Paediatrics), By Indication (Asthma, COPD, and Others),
• Aerosol Delivery Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Aerosol Delivery Devices Type Segment

In the aerosol delivery devices type segment, the smart inhaler devices segment is expected to hold a significant market share during the forecasted period. This is owing to the growing pharmaceutical companies collaborating with digital health companies for developing smart inhaler devices. For instance, in May 2020, Propeller Health, one of the leading digital health companies dedicated to the management of asthma and COPD received FDA clearance to bring its connected platform to AstraZeneca's Symbicort to help digitize the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Aerosol Delivery Devices Market Companies

Some of the key market players operating in the Aerosol Delivery Devices market include Novartis AG, AstraZeneca, GlaxoSmithKline plc, CHIESI Farmaceutici S.p.A., Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd., OMRON, Koninklijke Philips N.V., PARI GmbH, Boehringer Ingelheim International GmbH., Glenmark Pharmaceuticals Limited, Lepu Medical Technology(Beijing)Co.,Ltd., Rossmax International Ltd, Promed Technology Co., Limited, HELTMAN Medikal A.S., Pneuma Respiratory., Cipla Inc., Microlife Corporation., Honsun, and others.
Aerosol Delivery Devices Market Growth Factors
However, certain factors such as the lack of a single, effective device for every respiratory disorder and availability of alternative therapies such as oral medications, subcutaneous injections are expected to pose a challenge to the Aerosol Delivery Devices market growth.

Request Sample Report- https://www.delveinsight.com/sample-request/aerosol-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Aerosol Delivery Devices Market Report Introduction
2. Aerosol Delivery Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Aerosol Delivery Devices Market Key factors analysis
5. Aerosol Delivery Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Aerosol Delivery Devices Market
7. Aerosol Delivery Devices Market layout
8. Aerosol Delivery Devices Global Company Share Analysis - Key 3-5 Companies
9. Aerosol Delivery Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Do you have any query related to the report? If yes, click here- https://www.delveinsight.com/report-store/aerosol-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.